USA Daily Letter
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

USA Daily Letter

Investing

Acceleration of RAD204 Phase 1 dose escalation trial

by May 12, 2025
May 12, 2025
Acceleration of RAD204 Phase 1 dose escalation trial

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com
0
FacebookTwitterGoogle +Pinterest
previous post
Multiple New Multi-Commodity Targets
next post
A bridge builder and quiet reformer. How Pope Leo will lead the Catholic Church

You may also like

Update – Blackstone Merger to Acquire Copper Gold...

Crypto Market Recap: Bitcoin Breaks US$100,000 as ETF...

AngloGold Sells Two African Assets to Resolute Mining

Lundin Mining Declares Filo del Sol a “Generational”...

Los Andes Copper at 121 Mining Investment London

Metals and Mining Virtual Investor Conference: Presentations Now...

Significant intercepts of gold and copper show Golden...

3 Things Warren Buffett Has Said About Gold

Gold Price Dips, Markets Stay Flat as Fed...

Triumph Gold: Multi-million-ounce, District-scale Gold Assets in the...

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • 4th round of US-Iran talks ends as Trump set to embark on...

    • Missiles, drones and airstrikes, until a sudden ceasefire. How India and Pakistan agreed to an uneasy truce

    • In China, some see the ghost of Mao as Trump upends America and the world

    • Pope! Amigo! Peruvians remember the young American priest who became pope

    • Dozens of boxes of Nazi materials found in basement at top Argentinian court

    Categories

    • Business (10)
    • Investing (60)
    • Politics (76)
    • World (61)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: usadailyletter.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 usadailyletter.com | All Rights Reserved


    Back To Top